Cheung Lily sold PLRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001746473-26-000010

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 20, 2026

Published

Jan 22, 2026

Ingested by INSIDER

Nov 5, 04:21 UTC

Last re-read

Nov 5, 04:21 UTC

Extracted facts

Filer

Cheung Lily

Role

Chief Human Resource Officer

Transaction

Open-market saleAs filed: “S”

Asset

PLIANT THERAPEUTICS, INC.

Ticker

PLRX

Shares

7,534

Price per share

$1.28

Value

$9,644

Execution date (reported)

Jan 20, 2026

Owned after transaction

44.8K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Cheung Lily filed this Form 4 reporting a open-market sale of PLRX on Jan 20, 2026. It became public on Jan 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Human Resource Officer

Cheung Lilycik:0001962207

Issuer

PLIANT THERAPEUTICS, INC.cik:0001746473

Revision history · 0

No field has changed since this record was first ingested.